ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - rotavirus g2 human-bovine reassortant, quantity: 1400000 infectious unit/ml; rotavirus g3 human-bovine reassortant, quantity: 1100000 infectious unit/ml; rotavirus g1 human-bovine reassortant, quantity: 1100000 infectious unit/ml; rotavirus g4 human-bovine reassortant, quantity: 1000000 infectious unit/ml; rotavirus p1 [8] human-bovine reassortant, quantity: 1150000 infectious unit/ml - oral liquid - excipient ingredients: polysorbate 80; sucrose; sodium citrate dihydrate; sodium hydroxide; monobasic sodium phosphate; glucose monohydrate; sodium ascorbate; sodium chloride; ammonium metavanadate; calcium chloride dihydrate; cupric sulfate pentahydrate; ferric nitrate nonahydrate; ferrous sulfate heptahydrate; magnesium chloride hexahydrate; dried magnesium sulfate; manganese sulfate tetrahydrate; ammonium molybdate; potassium chloride; sodium acetate; sodium bicarbonate; dibasic sodium phosphate; zinc sulfate heptahydrate; alanine; arginine hydrochloride; asparagine; aspartic acid; cysteine hydrochloride; cystine dihydrochloride; glutamic acid; glycine; histidine hydrochloride monohydrate; hydroxyproline; isoleucine; leucine; lysine hydrochloride; methionine; phenylalanine; proline; serine; threonine; tryptophan; tyrosine disodium; valine; biotin; ergocalciferol; choline chloride; folic acid; inositol; menadione; nicotinamide; nicotinic acid; aminobenzoic acid; calcium pantothenate; pyridoxal hydrochloride; pyridoxine hydrochloride; retinol acetate; riboflavine; dl-alpha-tocopheryl phosphate disodium; thiamine hydrochloride; cyanocobalamin; adenine sulfate dihydrate; adenosine triphosphate disodium; adenosine monophosphate; cholesterol; deoxyribose; glutathione; guanine hydrochloride; sodium hypoxanthine; linoleic acid; alpha lipoic acid; phenolsulfonphthalein; putrescine dihydrochloride; sodium pyruvate; ribose; thymidine; thymine; uracil; sodium xanthine; monoethanolamine; 2-mercaptoethanol; adenosine; uridine; cytidine; guanosine; dexamethasone; epidermal growth factor; hydrocortisone; insulin; alprostadil; liothyronine; ascorbic acid; magnesium sulfate heptahydrate; monobasic sodium phosphate monohydrate; zinc sulfate; arginine; cysteine; cystine; histidine; lysine; tyrosine; adenosine triphosphate; guanine; putrescine - rotateq is indicated for the prevention of rotavirus gastroenteritis (see clinical trials).

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: water for injections; sodium chloride; monobasic potassium phosphate; dibasic sodium phosphate dihydrate; magnesium chloride hexahydrate; potassium chloride - for the prevention of influenza caused by influenza virus, types a and b contained in the vaccine. the vaccine is indicated for use in adults and children 6 months of age and older. for full details regarding recommendations for influenza vaccination, please refer to the relevant national immunisation guidelines.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: water for injections; sodium chloride; monobasic potassium phosphate; dibasic sodium phosphate dihydrate; magnesium chloride hexahydrate; potassium chloride - for the prevention of influenza caused by influenza virus, types a and b contained in the vaccine. the vaccine is indicated for use in adults and children 6 months of age and older. for full details regarding recommendations for influenza vaccination, please refer to the relevant national immunisation guidelines.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

catalent australia pty ltd - nicotinamide, quantity: 20 mg; pyridoxine hydrochloride, quantity: 2 mg (equivalent: pyridoxine, qty 1.65 mg); cyanocobalamin, quantity: 0.003 mg; panax ginseng, quantity: 20 mg; ascorbic acid, quantity: 60 mg; thiamine hydrochloride, quantity: 1.5 mg; calcium pantothenate, quantity: 10 mg; riboflavine, quantity: 1.5 mg; retinol palmitate, quantity: 5000 iu (equivalent: vitamin a, qty 5000 iu); dl-alpha-tocopheryl acetate, quantity: 75 mg; calcium hydrogen phosphate, quantity: 307 mg (equivalent: calcium, q - capsule, soft - excipient ingredients: lecithin; hydrogenated vegetable oil; yellow beeswax; linseed oil; wheatgerm oil; soya oil; gelatin; vanillin; allura red ac; brilliant blue fcf; titanium dioxide; sunset yellow fcf; methyl hydroxybenzoate; propyl hydroxybenzoate; glycerol; purified water; mannitol

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

catalent australia pty ltd - colecalciferol, quantity: 5 microgram; heavy magnesium oxide, quantity: 49.8 mg (equivalent: magnesium, qty 30 mg); calcium carbonate, quantity: 875 mg (equivalent: calcium, qty 350 mg); zinc oxide, quantity: 6.2 mg (equivalent: zinc, qty 5 mg); cyanocobalamin, quantity: 0.05 mg - capsule, soft - excipient ingredients: dibasic sodium phosphate; hydrogenated vegetable oil; glycerol; titanium dioxide; soya oil; colloidal anhydrous silica; carrageenan; hydroxypropyl starch; polysorbate 80; yellow beeswax; iron oxide yellow; lecithin; purified water; mannitol - maintain/support general health and wellbeing

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

catalent australia pty ltd - natural fish oil, quantity: 1 g (equivalent: docosahexaenoic acid, qty 120 mg; equivalent: eicosapentaenoic acid, qty 180 mg; equivalent: omega-3 marine triglycerides, qty 300 mg) - capsule, soft - excipient ingredients: d-alpha-tocopherol; carrageenan; hydroxypropyl starch; purified water; glycerol; dibasic sodium phosphate - maintain/support general health and wellbeing ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency

यूरोपीय संघ - अंग्रेज़ी - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - split influenza virus inactivated, containing antigen equivalent to a/california/07/2009 (h1n1)-derived strain used nymc x-179a - influenza, human; immunization; disease outbreaks - influenza vaccines - prophylaxis of influenza caused by a (h1n1)v 2009 virus. pandemrix should only be used if the recommended annual seasonal trivalent / quadrivalent influenza vaccines are not available and if immunisation against (h1n1)v is considered necessary (see sections 4.4 and 4.8).pandemrix should be used in accordance with official guidance.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

catalent australia pty ltd - ascorbic acid, quantity: 500 mg; zinc oxide, quantity: 18.6 mg (equivalent: zinc, qty 15 mg); d-alpha-tocopherol, quantity: 268 mg; cupric sulfate, quantity: 5.04 mg (equivalent: copper, qty 2 mg); lutein, quantity: 10 mg; zeaxanthin, quantity: 2 mg - capsule, soft - excipient ingredients: hydrogenated vegetable oil; soya oil; yellow beeswax; lecithin; polysorbate 80; gelatin; iron oxide black; iron oxide red; propylene glycol; glycerol; purified water; vegetable oil; safflower oil; dl-alpha-tocopherol; maize oil; titanium dioxide; ethyl acetate; isopropyl alcohol; ethanol; strong ammonia solution; polyvinyl acetate phthalate; macrogol 400

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

catalent australia pty ltd - cupric sulfate, quantity: 5.04 mg (equivalent: copper, qty 2 mg); zinc oxide, quantity: 18.6 mg (equivalent: zinc, qty 15 mg); ascorbic acid, quantity: 500 mg; d-alpha-tocopherol, quantity: 268 mg; zeaxanthin, quantity: 2 mg; lutein, quantity: 10 mg - capsule, soft - excipient ingredients: propylene glycol; hydrogenated vegetable oil; purified water; iron oxide black; glycerol; iron oxide red; polysorbate 80; yellow beeswax; soya oil; gelatin; vegetable oil; lecithin; maize oil; dl-alpha-tocopherol; titanium dioxide; ethyl acetate; isopropyl alcohol; ethanol; strong ammonia solution; polyvinyl acetate phthalate; macrogol 400; safflower oil - maintain/support general health and wellbeing

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

sanofi pasteur inc. - influenza a virus a/victoria/2570/2019 ivr-215 (h1n1) antigen (formaldehyde inactivated) (unii: wd5e5vym2e) (influenza a virus a/victoria/2570/2019 ivr-215 (h1n1) hemagglutinin antigen (formaldehyde inactivated) - unii:erb9sj9vmq), influenza a virus a/darwin/9/2021 san-010 (h3n2) antigen (formaldehyde inactivated) (unii: kja387fhb2) (influenza a virus a/darwin/9/2021 san-010 (h3n2) hemagglutinin antigen (formaldehyde inactivated) - unii:6s4y8a8uey), influenza b virus b/phuket/3073/2013 antigen (formaldehy - influenza a virus a/michigan/45/2015 x-275 (h1n1) hemagglutinin antigen (formaldehyde inactivated) 15 ug in 0.5 ml - fluzone® quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza a subtype viruses and type b viruses contained in the vaccine. fluzone quadrivalent is approved for use in persons 6 months of age and older. do not administer fluzone quadrivalent to anyone with a history of a severe allergic reaction (e.g., anaphylaxis) to any component of the vaccine [see description (11) ], including egg protein, or to a previous dose of any influenza vaccine. pregnancy exposure registry sanofi pasteur inc. is maintaining a prospective pregnancy exposure registry to collect data on pregnancy outcomes following vaccination with fluzone quadrivalent during pregnancy. healthcare providers are encouraged to enroll women who receive fluzone quadrivalent during pregnancy in sanofi pasteur inc.'s vaccination pregnancy registry by calling 1-800-822-2463. risk summary all pregnancies have a risk of birth defect, loss, or other adverse outcomes. in the u.s. general popul